Sertac

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sertac

Property Description
Active ingredient Sertraline hydrochloride
Form Tablet (primary oral form), Capsule, Oral Solution
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
General purpose Support for mood stabilization and emotional balance
Origin Synthetic compound

What Type of Medicine is Sertac? (Classification and Identity)

Sertac is the trade name for a prescription-only psychotropic medicine whose active component is Sertraline hydrochloride. It is formally classified as an antidepressant belonging to the group of Selective Serotonin Reuptake Inhibitors (SSRIs). This classification is clinically recognized for its focused action compared to older, less selective antidepressant types. Sertraline, as a synthetic compound, offers a defined and predictable pharmacological profile, with its single-ingredient status being a key feature that simplifies clinical management compared to combination products.

Composition and Physical Form of Sertac (Contents and Delivery)

Sertac is composed solely of the therapeutic substance Sertraline hydrochloride. The medication is most typically supplied for oral administration in the tablet form, ensuring systemic absorption through the digestive tract. Sertraline's mechanism is linked to inhibiting the neuronal uptake of serotonin. This oral delivery method is the standard for Sertraline and is supported by widespread clinical practice for achieving the necessary systemic concentrations to affect the Central Nervous System (CNS).

General Therapeutic Role of Sertraline (High-Level Purpose)

The general therapeutic purpose of Sertraline is to assist the Central Nervous System (CNS) in regulating mood and stabilizing emotional processing. Its function as an SSRI facilitates an increase in available serotonin in the neural pathways. This chemical modification helps to stabilize and support the brain’s internal chemistry, with the overall role of the compound being to promote long-term stability in mood regulation. The sustained administration of this compound is often employed in situations requiring long-term mood support and the improvement of daily emotional functioning.

Regulatory References

  1. Sertraline (Zoloft) - NIH StatPearls

What side effects are possible with Sertac?

Sertac (sertaconazole nitrate) topical cream is generally well-tolerated. However, like all medications, it may cause side effects, primarily related to the application site.


Common Side Effects

Side effects that may occur at the application site are typically mild and temporary. These may include:

  • Burning or stinging sensation
  • Dry skin
  • Itching (pruritus)
  • Redness (erythema)
  • Application site tenderness

If these effects are persistent or worsen, you should consult your healthcare provider.


Serious Warnings and Precautions

Hypersensitivity

Sertac is contraindicated in patients with a known hypersensitivity to sertaconazole, other imidazole antifungal agents (such as clotrimazole or ketoconazole), or any of the inactive ingredients in the formulation. Discontinue use and seek immediate medical attention if signs of a serious allergic reaction occur, such as: severe rash, hives, blistering, difficulty breathing, or swelling of the face, lips, tongue, or throat.

Administration

Sertac is for external dermal use only. It must not be used for ophthalmic (eye), oral, or intravaginal administration. If accidental contact with the eyes or mucous membranes occurs, rinse thoroughly with water.

Pregnancy and Breastfeeding

  • Pregnancy: There are no adequate and well-controlled studies in pregnant women. Sertac should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult your doctor.
  • Breastfeeding: It is unknown whether sertaconazole is excreted in human milk. Caution should be exercised when prescribing Sertac to a nursing woman. Consult your doctor for advice.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented manifestations and required emergency actions for an overdose of Sertraline (Sertac) as described in government regulatory documents.


Official Manifestations and Severe Risks

Overdose of Sertraline, whether taken alone or with other substances, has been associated with specific clinical manifestations, though often milder than older antidepressants. However, death has been reported, primarily in cases involving multiple drug ingestions.

System Documented Manifestations Severe Outcomes
CNS Somnolence, Dizziness, Tremor, Agitation, Altered Mental Status Seizures, Coma, Serotonin Syndrome
Cardiovascular Tachycardia, Hypertension QRS and QTc interval prolongation (Toxicity)

Required Emergency Action

Any suspected overdose of Sertraline requires aggressive medical treatment and immediate attention as no specific antidote exists for Sertraline.

  • Seek immediate medical attention and/or contact emergency services immediately if an overdose is suspected.
  • Hospital Monitoring: Regulatory documents mandate comprehensive ECG monitoring and continuous vital sign checks to manage potential cardiac and neurological complications.
  • Management Notes: Supportive measures, including establishing and maintaining an airway, are required. Activated charcoal may be considered, but dialysis and forced diuresis are considered unlikely to be beneficial.

Therapeutic Uses of Sertac

What Sertac Treats: Main Uses and Benefits

Sertac is commonly used across conditions presenting with acute or disruptive symptom patterns in the therapeutic domains of mood, anxiety, and trauma. The medication is considered relevant for conditions involving episodic or fluctuating manifestations, and is commonly used to help with conditions such as Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Post-Traumatic Stress Disorder (PTSD), Social Anxiety Disorder, and Premenstrual Dysphoric Disorder (PMDD).


Mood Stabilization and Symptom Relief

Sertac may assist with easing symptoms related to persistent low mood, loss of pleasure (anhedonia), and emotional fatigue. It supports the patient during difficult episodes by easing distress and may assist with maintaining a sense of stability when symptoms are more noticeable. In settings where symptoms become temporarily overwhelming, Sertac is relevant for easing symptoms related to excessive worry, and may assist with managing the frequency of unexpected panic attacks. The medication helps address symptom clusters that may become intense or disruptive, such as unwanted, recurrent obsessions and trauma-related distress like flashbacks.

“This use contributes to easing the overall symptom load.”

Quick Fact: Supports managing Intrusive Thoughts and Emotional Fatigue.

Regulatory References

  1. TGA (Therapeutic Goods Administration) for Zoloft

Eligibility and Restrictions for Use

Eligibility Scope

The use of Sertac (sertraline) is determined by official population-based criteria outlined in regulatory labeling.

Populations for whom use is contraindicated (Must Not Use):

  • Patients with documented hypersensitivity to sertraline or any component of the product.
  • Individuals currently taking Monoamine Oxidase Inhibitors (MAOIs), including linezolid or intravenous methylene blue, or within 14 days of discontinuing an MAOI.
  • Concomitant use with pimozide is prohibited.

Age-Related Eligibility Rules:

  • Use is approved for adults (18+ years) for all labeled indications.
  • In pediatric patients (aged 6–17 years), use is established only for the treatment of Obsessive-Compulsive Disorder (OCD).
  • Safety and efficacy have not been established for children under 6 years of age.

Condition-Specific Eligibility Rules (Conditional Use):

  • Patients with severe hepatic impairment should not use the medicine, as no clinical data are available in this group.
  • Use requires caution in patients with mild to moderate hepatic impairment.
  • Sertraline should be avoided in patients with unstable epilepsy and in those with untreated or anatomically predisposed angle-closure glaucoma.
  • No dosage adjustment is typically necessary for patients based solely on renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes the official regulatory information regarding potential interactions when using Sertac (Sertaconazole nitrate topical formulation).

Systemic Drug-Drug Interaction Profile

The regulatory profile for Sertaconazole topical is defined by the minimal systemic absorption observed after application. Due to this low absorption, the systemic plasma concentrations of Sertaconazole are typically minimal or undetectable. Consequently, official government regulatory documents do not list specific clinically significant systemic drug-drug interactions.

Pharmacokinetic and Pharmacodynamic Considerations

Official labels state that comprehensive studies on drug interactions, including those involving cytochrome P450 (CYP) enzymes or drug transporters, have not been systematically evaluated for the topical product. This is consistent with the product's minimal systemic exposure, which makes systemic pharmacokinetic interactions (such as changes in AUC or Cmax) or pharmacodynamic interactions (such as additive effects) unlikely to be clinically relevant.

Contraindications and Co-administration

No specific medicinal products or product classes are explicitly listed as contraindicated combinations with Sertaconazole topical in official interaction sections. Similarly, regulatory documents do not specify requirements for separating the administration time of Sertac from other medications or products.

Food, Alcohol, and Herbal Products

Official labeling does not include specific interaction statements or warnings concerning the use of food, alcohol, or herbal products while using the topical formulation.

Mechanism of Action

Sertac (Sertaconazole) acts through two primary mechanistic domains within the fungal cell to implement its biochemical action.

Ergosterol Biosynthesis Inhibition

This mechanism involves the drug acting as an azole antifungal, inhibiting the cytochrome P450-dependent enzyme 14alpha-demethylase. This critical enzyme is essential for converting lanosterol into ergosterol, a vital component for the structural and functional organization of the fungal cell membrane. The resulting depletion of ergosterol contributes to altered structural and functional properties of the membrane.


Direct Membrane Damage and Permeability

At higher concentrations, Sertac engages a second, distinct mechanism by directly binding to non-sterol lipids within the fungal cell wall. This direct engagement increases the cell wall's permeability, leading to the rapid efflux of essential intracellular components, such as ATP. This effect promotes the rapid cessation of fungal physiological function.

Dosage and Administration Information

Official Instructions for Using Sertac Cream

Sertac (sertaconazole nitrate) Cream, 2%, is for topical dermatologic use only and must be administered strictly according to established instructions for patients 12 years of age and older.


Administration and Dosing Schedule

Instruction Component Official Requirement
Route External use on the skin only. Not for ophthalmic, oral, or intravaginal use.
Frequency Twice daily (every 12 hours).
Duration Apply for the full treatment time of four weeks, even if symptoms have improved.
Age Group For use in patients 12 years of age and older.

Procedural Steps

  1. Preparation: If applying after bathing, the affected skin area must be thoroughly dried before the cream is used.
  2. Application: Apply a sufficient amount of cream to cover both the affected area and the immediately surrounding healthy skin.
  3. Post-Application: Wash hands thoroughly with soap and water after applying the medication.
  4. Coverings: Avoid the use of occlusive dressings (bandages or wraps) on the treated area unless specifically directed to do so by a healthcare provider.

Missed Dose

If a dose is missed, apply it as soon as it is remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and continue with the regular dosing schedule. Do not apply extra cream to try and make up for a missed dose.

Recent Clinical Evidence

Research evidence / Overview of studies for Sertac

Evidence for Use in Major Depressive Disorder (MDD)

The research on Sertac for Major Depressive Disorder (MDD) has involved various types of controlled trials. These include short-term Randomized Controlled Trials (RCTs), used in research exploring how symptoms change over time in adult outpatients. Studies were also conducted on children and adolescents, focusing on outcomes related to symptom intensity or variability using standardized rating scales. Research highlights patterns where measured changes in the compound group were different from measured changes in the placebo group on scales assessing overall depressive severity. The time to symptom recurrence was a focus of the research for certain patients who had achieved remission.

Evidence for Obsessive-Compulsive Disorder (OCD)

The use of Sertac was studied for Obsessive-Compulsive Disorder (OCD) through multiple acute and long-term placebo-controlled RCTs for both adults and pediatric populations (children and adolescents). The main outcomes measured were related to reducing the severity of OCD symptoms using clinical rating scales. Research highlights patterns where measured changes in symptom severity in the compound group were reported differently compared to the placebo group. Studies explored the potential relationship between higher dosing and measured changes in symptom scores for this indication.

Understanding Research Gaps and Uncertainty

Research highlights what is known and what is still uncertain about Sertac, which is standard for all prescription medicines. Evidence is limited for patients with specific, severe medical comorbidities. One key gap is the inconsistency of findings observed in certain specific patient subgroups, such as those related to combat trauma, where data show patterns related to less robust measured symptom change in some short-term studies. This suggests that the results apply only to the populations studied and do not provide definitive predictions for every subgroup. Furthermore, follow-up durations were limited in some trials for long-term relapse prevention in Panic Disorder.

Frequently Asked Questions (FAQ)

Common questions about Sertac (FAQ)


Q: What is the main difference between Sertac and other medicines used for the same condition?

A: According to official product information, Sertac (Sertraline) is chemically classified as a Selective Serotonin Reuptake Inhibitor (SSRI). This classification distinguishes it from older medicine types, such as tricyclics or tetracyclic antidepressants. While used for similar conditions, its pharmacological profile and focused action are key distinguishing characteristics.


Q: How long does it usually take to notice the effects of Sertac?

A: Clinical studies suggest some early therapeutic effect might be observed during the first week of use. However, official documents state that a full therapeutic response often requires a longer period of time. Achieving the full benefit often requires continued use, as described in regulatory information.


Q: Is Sertac considered safe for older people?

A: Official safety information indicates that use in patients aged 65 and older requires careful monitoring. Regulatory documents mention potential risks, such as hyponatremia (low sodium levels in the blood), which are important to recognize. While studies did not show an increased risk of suicidality compared to placebo in older adults, monitoring is necessary.


Q: What is the recommended period of time to use Sertac?

A: The duration of Sertac use is determined by a healthcare provider based on the condition being treated. For chronic conditions like depression, regulatory information suggests treatment often continues for several months or more after a patient's symptoms have improved. This is to help prevent the recurrence of symptoms.


Q: Is the evidence for Sertac's use considered strong?

A: Regulatory approval for Sertac is based on data from numerous clinical studies, including placebo-controlled randomized trials (RCTs). These studies examined the drug's efficacy across its various approved uses, such as Major Depressive Disorder and Obsessive-Compulsive Disorder. These trials are the standard basis for establishing the effectiveness of prescription medicines.


Q: How should I handle a missed dose of Sertac?

A: Regulatory instructions advise skipping the missed dose and taking the next scheduled dose at the regular time. It is stated that taking extra medicine to compensate for a missed dose is not advised.


Q: Does the time of day matter when taking Sertac?

A: Sertac is generally taken once a day, and the time of day is flexible (morning or evening). Official information notes that if drowsiness (somnolence) occurs, the medication is sometimes administered in the evening.


Q: What is the difference between brand-name Sertac and its generic version?

A: Sertac is a brand name for the active ingredient Sertraline. Generic versions of Sertraline contain the same active therapeutic substance. Regulatory standards ensure that generic forms are considered therapeutically equivalent to the brand-name product.


Q: Can Sertac be taken with other medicines for mental health conditions?

A: Official regulatory documents prohibit the concomitant use of Sertac with Monoamine Oxidase Inhibitors (MAOIs) or the drug Pimozide. Additionally, caution is generally required when combining it with other medicines that may increase serotonin levels, such as certain pain or mood stabilizers, due to the potential risk of Serotonin Syndrome.


Q: Is there any research on long-term effects of using Sertac for many years?

A: Research has examined the long-term use of Sertac for maintenance of treatment response. Efficacy has been established in studies for preventing the recurrence of Major Depressive Disorder and for maintaining treatment response in Obsessive-Compulsive Disorder. These long-term studies help to define the drug's role in chronic conditions.


Q: What happens if I stop taking Sertac suddenly?

A: Abruptly stopping the medication is not recommended, as it may lead to discontinuation symptoms. These symptoms can include dizziness, nausea, and changes in sleep or sensation. Official guidance indicates that dose reduction should occur gradually under the supervision of a healthcare professional.


Q: Is Sertac known to cause drowsiness or affect driving?

A: Drowsiness, or somnolence, is listed as a common side effect in official documents. Regulatory warnings state that caution should be exercised when driving or operating complex machinery until the patient knows how the medicine affects them.


Q: Is it normal to feel a bit nauseous when starting Sertac?

A: Nausea is listed as one of the very common side effects reported during clinical trials for the medication. This reaction frequently occurs in a significant percentage of patients when they first begin taking the medication.


Q: Is there a link between Sertac use and changes in weight?

A: Official adverse reaction profiles indicate that changes in appetite and weight loss can occur with Sertac use. Weight change is listed as part of the known side effect profile reported in clinical trials for the drug.


Q: How long after stopping Sertac does it stay in the body?

A: Official pharmacokinetic information states that the average terminal elimination half-life of Sertraline is approximately 26 hours. The half-life refers to the time it takes for the concentration of the substance in the body to be reduced by half.


Q: Is Sertac a habit-forming or addictive medicine?

A: Sertac (Sertraline) is not classified as a controlled substance by regulatory bodies. While official documents do not describe it as habit-forming or a drug of abuse, abruptly discontinuing the medicine can lead to a discontinuation syndrome.


Q: What is the purpose of the black box warning (if any) on Sertac packaging?

A: The product packaging includes a Boxed Warning, which is the most serious level of warning required by the FDA. This warning concerns the increased risk of suicidal thoughts and behavior in children, adolescents, and young adults (up to age 24) observed in short-term studies of this class of medicine.


Q: Does Sertac affect blood pressure or heart rate?

A: Palpitations (abnormal heart rhythm) are listed among potential side effects. Official information also notes that caution is required in patients who have risk factors for QTc prolongation, which is a specific type of heart rhythm issue.


Q: Can men use Sertac if they are planning to conceive?

A: Official patient documentation notes that common side effects in men include various sexual problems. These can involve a decreased sex drive (libido) or issues with erection and ejaculation.


Q: Is Sertac available as a generic medicine?

A: Yes, the active ingredient in Sertac, which is sertraline, is available as a generic medicine.


Q: Are there any special instructions for people with diabetes taking Sertac?

A: Official guidance states that use requires caution in patients with diabetes. This is because the medication has the potential to affect blood sugar control.


Q: Is it common for people to report headaches when taking Sertac?

A: Headaches are explicitly listed in official patient information as a common side effect of the medication.


Q: Do I need to have regular blood tests while using Sertac?

A: Patients may require monitoring, such as blood tests, during treatment for certain conditions. This is to check for issues like hyponatremia (low blood sodium levels) or to screen for bipolar disorder.


Q: Is it true that Sertac is not recommended for people with certain heart conditions?

A: Official information states that the use of Sertac requires caution in individuals with pre-existing heart disease. This includes those who have risk factors for a specific heart rhythm issue called QTc prolongation.


Q: Can Sertac affect the effectiveness of birth control pills?

A: Official regulatory documents and clinical studies typically do not state that Sertraline affects the effectiveness of oral contraceptive pills. Specific interactions are not generally listed for this combination.


Q: Is Sertac known to cause sun sensitivity?

A: Although photosensitivity is not classified as a common adverse reaction in core data, patients are sometimes advised to take precautions in the sun. This is a general caution sometimes given for this class of medicine.


Q: What are some common reasons people stop taking Sertac?

A: Official records from clinical trials list the most common adverse reactions that caused patients to discontinue the medicine. These include gastrointestinal issues like nausea and diarrhea, as well as insomnia, fatigue, and ejaculation failure in men.


Q: What should I know about taking Sertac before having surgery?

A: Official patient information indicates that individuals should inform their physician, surgeon, or dentist that they are taking Sertac before any medical or surgical procedures. This allows the medical team to take the medication into consideration during the procedure.


Q: Is it better to take Sertac with or without food?

A: Sertac can be taken either with or without food. However, if the medication causes any stomach upset or gastrointestinal distress, official sources sometimes note that taking it alongside food may be considered.


Q: Can Sertac affect sleep patterns?

A: Official adverse reaction documents list both insomnia (trouble sleeping) and somnolence (excessive drowsiness) as common side effects. The medication therefore has the potential to affect various sleep patterns.

How should Sertac be stored and disposed of?

Official Storage and Disposal Requirements

Sertraline tablets and capsules must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with regulated excursions permitted between 15 C and 30 C. The medicine must be kept in its original container, tightly closed, and stored in a dry place, protected from moisture and excessive heat. Freezing is prohibited.

All medicine must be stored in a secure location out of the reach of children and pets.

For disposal of unused or expired product, the preferred method is to utilize an official drug take-back program. If this is unavailable, the product may be mixed with an undesirable substance (like coffee grounds), placed in a sealed bag, and then discarded in the household trash. The regulatory guidance also stresses avoiding release into the environment, sewers, or surface water, and requires removing all identifying personal information from the label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sertac found in:

A-Z Index: